NO20031741L - Anvendelse av progestiner for induksjon av apoptose i en celle - Google Patents
Anvendelse av progestiner for induksjon av apoptose i en celleInfo
- Publication number
- NO20031741L NO20031741L NO20031741A NO20031741A NO20031741L NO 20031741 L NO20031741 L NO 20031741L NO 20031741 A NO20031741 A NO 20031741A NO 20031741 A NO20031741 A NO 20031741A NO 20031741 L NO20031741 L NO 20031741L
- Authority
- NO
- Norway
- Prior art keywords
- cell
- antiprogestin
- apoptosis
- progestins
- induction
- Prior art date
Links
- 230000006882 induction of apoptosis Effects 0.000 title 1
- 239000000583 progesterone congener Substances 0.000 title 1
- 230000000708 anti-progestin effect Effects 0.000 abstract 4
- 239000003418 antiprogestin Substances 0.000 abstract 4
- -1 4-acetylphenyl Chemical group 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000018199 S phase Effects 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000022131 cell cycle Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24099100P | 2000-10-18 | 2000-10-18 | |
| EP00250342 | 2000-10-18 | ||
| PCT/EP2001/012006 WO2002032432A1 (en) | 2000-10-18 | 2001-10-17 | Use of antiprogestins for the induction of apoptosis in a cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20031741D0 NO20031741D0 (no) | 2003-04-15 |
| NO20031741L true NO20031741L (no) | 2003-06-17 |
Family
ID=26072952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20031741A NO20031741L (no) | 2000-10-18 | 2003-04-15 | Anvendelse av progestiner for induksjon av apoptose i en celle |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1326617B9 (el) |
| JP (1) | JP2004511523A (el) |
| KR (1) | KR100668024B1 (el) |
| CN (1) | CN1209111C (el) |
| AT (1) | ATE334683T1 (el) |
| AU (2) | AU2361902A (el) |
| BG (1) | BG107744A (el) |
| BR (1) | BR0114696A (el) |
| CA (1) | CA2423020C (el) |
| CY (1) | CY1105745T1 (el) |
| CZ (1) | CZ299823B6 (el) |
| DE (1) | DE60121980T2 (el) |
| DK (1) | DK1326617T3 (el) |
| EA (1) | EA010593B1 (el) |
| EE (1) | EE200300157A (el) |
| ES (1) | ES2269492T3 (el) |
| HK (1) | HK1062273A1 (el) |
| HR (1) | HRP20030388A2 (el) |
| HU (1) | HUP0301433A3 (el) |
| IL (2) | IL154976A0 (el) |
| MX (1) | MXPA03002955A (el) |
| NO (1) | NO20031741L (el) |
| NZ (1) | NZ538347A (el) |
| PL (1) | PL360157A1 (el) |
| PT (1) | PT1326617E (el) |
| SI (1) | SI1326617T1 (el) |
| SK (1) | SK4702003A3 (el) |
| UA (1) | UA76729C2 (el) |
| WO (1) | WO2002032432A1 (el) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY27301A1 (es) * | 2001-05-25 | 2003-02-28 | Schering Ag | Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata |
| US20040242551A1 (en) * | 2003-05-28 | 2004-12-02 | Schering Ag | Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
| WO2008128791A2 (en) * | 2007-04-23 | 2008-10-30 | Bayer Schering Pharma Aktiengesellschaft | Progesterone-receptor antagonist for use in brca-mediated cancer alone or as combination with antiestrogen |
| US20080268041A1 (en) * | 2007-04-23 | 2008-10-30 | Jens Hoffmann | Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases |
| JP2010524996A (ja) * | 2007-04-23 | 2010-07-22 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | Ｂｒｃａ媒介性疾患における使用のための、プロゲステロン受容体拮抗薬と、ルテインホルモン放出ホルモン作動薬および拮抗薬との組み合わせ |
| GB0718167D0 (en) | 2007-09-18 | 2007-10-31 | Cancer Rec Tech Ltd | Cancer marker and therapeutic target |
| CN103957920B (zh) * | 2011-10-04 | 2018-04-20 | 因维维斯制药公司 | 用于鉴定和治疗抗黄体制剂敏感性肿瘤的方法和系统 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19706061A1 (de) * | 1997-02-07 | 1998-08-13 | Schering Ag | Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette |
-
2001
- 2001-10-17 PT PT01987669T patent/PT1326617E/pt unknown
- 2001-10-17 SK SK470-2003A patent/SK4702003A3/sk not_active Application Discontinuation
- 2001-10-17 CA CA002423020A patent/CA2423020C/en not_active Expired - Fee Related
- 2001-10-17 AU AU2361902A patent/AU2361902A/xx active Pending
- 2001-10-17 SI SI200130648T patent/SI1326617T1/sl unknown
- 2001-10-17 AU AU2002223619A patent/AU2002223619B2/en not_active Ceased
- 2001-10-17 PL PL01360157A patent/PL360157A1/xx not_active Application Discontinuation
- 2001-10-17 HU HU0301433A patent/HUP0301433A3/hu unknown
- 2001-10-17 EA EA200300479A patent/EA010593B1/ru not_active IP Right Cessation
- 2001-10-17 EP EP01987669A patent/EP1326617B9/en not_active Expired - Lifetime
- 2001-10-17 KR KR1020037005360A patent/KR100668024B1/ko not_active IP Right Cessation
- 2001-10-17 WO PCT/EP2001/012006 patent/WO2002032432A1/en active IP Right Grant
- 2001-10-17 DK DK01987669T patent/DK1326617T3/da active
- 2001-10-17 CN CNB018175694A patent/CN1209111C/zh not_active Expired - Fee Related
- 2001-10-17 DE DE60121980T patent/DE60121980T2/de not_active Expired - Fee Related
- 2001-10-17 BR BR0114696-3A patent/BR0114696A/pt not_active Application Discontinuation
- 2001-10-17 CZ CZ20031073A patent/CZ299823B6/cs not_active IP Right Cessation
- 2001-10-17 MX MXPA03002955A patent/MXPA03002955A/es active IP Right Grant
- 2001-10-17 JP JP2002535670A patent/JP2004511523A/ja active Pending
- 2001-10-17 ES ES01987669T patent/ES2269492T3/es not_active Expired - Lifetime
- 2001-10-17 EE EEP200300157A patent/EE200300157A/xx unknown
- 2001-10-17 NZ NZ538347A patent/NZ538347A/en unknown
- 2001-10-17 UA UA2003054311A patent/UA76729C2/uk unknown
- 2001-10-17 IL IL15497601A patent/IL154976A0/xx active IP Right Grant
- 2001-10-17 AT AT01987669T patent/ATE334683T1/de not_active IP Right Cessation
-
2003
- 2003-03-18 IL IL154976A patent/IL154976A/en not_active IP Right Cessation
- 2003-04-15 NO NO20031741A patent/NO20031741L/no not_active Application Discontinuation
- 2003-04-18 BG BG107744A patent/BG107744A/bg unknown
- 2003-05-14 HR HR20030388A patent/HRP20030388A2/hr not_active Application Discontinuation
-
2004
- 2004-07-20 HK HK04105309A patent/HK1062273A1/xx not_active IP Right Cessation
-
2006
- 2006-11-01 CY CY20061101564T patent/CY1105745T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1104981T1 (el) | Χρηση των αντιπρογεστερονων για προληψη και αντιμετωπιση των εξαρτωμενων απο ορμονες ασθενειων | |
| NO986104D0 (no) | Progesteron-anti-progesteron regimer | |
| MY126768A (en) | Combinations of formoterol and fluticasone propionate for asthma | |
| HK1041829A1 (zh) | 糠酸毛他松在治療呼吸道和肺部疾病中的用途 | |
| MX9700309A (es) | Antagonista de progesterona y gestageno para el tratamiento de endometriosis y leiomyomata uteri. | |
| CY1105745T1 (el) | Χρηση της 11βητα-(4-ακετυλφαινυλ)-17βητα-υδροξυ-17αλφα(1,1,2,2-πενταφθοροαιθυλ)οιστρα-4,9-διεν-3-ονη για την παρασκευη ενος φαρμακου για την θεραπεια του καρκινου του μαστου, των ωοθηκων και του ενδομητριου, του μυελωματος και του μηνιγγιωματος | |
| YU29903A (sh) | Upotreba antiprogestina za indukciju apoptoze u ćeliji | |
| ATE270554T1 (de) | Kombination der progesteron und mifepristone für krebs-therapie | |
| TW200731977A (en) | Use of estradiol valerate in combination with dienogest for the oral treatment of dysfunctional uterine bleeding in conjunction with oral contraception | |
| JP2004511523A5 (el) | ||
| TW200733955A (en) | Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases | |
| EA200300480A1 (ru) | Применение антипрогестинов для профилактики и лечения гормонозависимых заболеваний | |
| DE4494826D2 (de) | Oral estrogen wirksame Ester des 14alpha,15alpha-Methylen-estradiols | |
| IT8322170A0 (it) | Composti atti al trattamento terapeutico delle alterazioni biliari, in particilare della bile litogena e dei calcoli colesterolici e composizioni farmaceutiche cheli contengono. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |